Earnings Feed
Start Free
Home/Filings/4/0001062993-24-006960
4//SEC Filing

Evans Elizabeth E. 4

Accession 0001062993-24-006960

CIK 0001205922other
View on SEC.govCompany Profile

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 4:33 PM ET

Size

15.6 KB

Accession

0001062993-24-006960

Insider Transaction Report

Form 4
Period: 2024-03-20
VACCINEX, INC.VCNX
Evans Elizabeth E.
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-20+1,341→ 1,341 total
    Exercise: $8.32Exp: 2034-03-20→ Common Stock (1,341 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $819.00Exp: 2029-03-14→ Common Stock (59 underlying)
    59

  • Stock Option (Right to Buy)

    Exercise: $802.20Exp: 2030-04-04→ Common Stock (47 underlying)
    47

  • Stock Option (Right to Buy)

    Exercise: $270.90Exp: 2032-04-01→ Common Stock (95 underlying)
    95

  • Stock Option (Right to Buy)

    Exercise: $83.90Exp: 2033-03-30→ Common Stock (190 underlying)
    190

  • Common Stock

    46

  • Stock Option (Right to Buy)

    Exercise: $1491.00Exp: 2025-12-22→ Common Stock (45 underlying)
    45

  • Stock Option (Right to Buy)

    Exercise: $1491.00Exp: 2025-12-23→ Common Stock (40 underlying)
    40

  • Stock Option (Right to Buy)

    Exercise: $615.30Exp: 2031-04-03→ Common Stock (38 underlying)
    38
Footnotes (6)
  • [F1]This option is fully exercisable as of the date of this report.
  • [F2]This option vests one-fourth on each of the first four anniversaries of the April 3, 2020 grant date, except as otherwise provided in the award notice.
  • [F3]This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice.
  • [F4]This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice.
  • [F5]This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice.
  • [F6]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date.

Documents

1 file

Issuer

VACCINEX, INC.

CIK 0001205922

→
Entity typeother

Related Parties

1
  • filerCIK 0001863447

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:33 PM ET
Size
15.6 KB
View on SEC.gov